Completed EARLY_PHASE1 INTERVENTIONAL 3-arm NCT02398383

Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes

Role of Glucagon in Glucose Control in Cystic Fibrosis Related Diabetes

Sponsor: Yale University

Conditions Cystic Fibrosis Cystic Fibrosis Related Diabetes

Interventions Hypoglycemic Clamp Mixed Meal Tolerance Test Oral Glucose Tolerance Test

Updated 8 times since 2017 Last updated: Jun 24, 2020 Started: Mar 31, 2015 Primary completion: Jun 22, 2017 Completion: Jun 22, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Cystic Fibrosis and Cystic Fibrosis Related Diabetes and is currently completed. Yale University leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jul 2020 — Jan 2021 [monthly]

Completed EARLY_PHASE1

Status: Unknown Status → Completed
Aug 2018 — Jul 2020 [monthly]

Unknown Status EARLY_PHASE1

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Aug 2018 [monthly]

Recruiting EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Recruiting EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Recruiting Phase 0

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States